Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Gastritis 3Peptic Ulcer 2Dyspepsia 2Stomach Ulcer 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1

Interventions

Bismuth 5Amoxicillin 4Tetracycline 3Esomeprazole 3Clarithromycin 3Furazolidone 2Rabeprazole 1Minocycline 1Berberine 11-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Dyspepsia × Furazolidone × Clear all
NCT07139366 2025-12-02

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Xijing Hospital of Digestive Diseases

Phase 4 Recruiting
1,248 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT04678492 2023-01-31

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
658 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡